$ALIM ALIMERA SCIENCES INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ALIMERA SCIENCES INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in ALIMERA SCIENCES INC. Insider overview, share value development, latest insider transactions and email notifications about new events in ALIMERA SCIENCES INC for free.

CIK Number: 0001267602
IRS Number: 200028718
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ALIM
Company Address: 6120 WINDWARD PARKWAY STE 290 ALPHARETTA 30005
Phone number: 678-990-5740

Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It operates through the following geographical segments: U.S. and International. The firm focuses on the development of ophthalmic pharmaceuticals for the treatment of diabetic macular edema, wet and dry age-related macular degeneration and retinal vein occlusion. Its products include ILUVIEN and NADPH Oxidase Inhibitors. The company was founded by Daniel C. Myers and David R. Holland on June 4, 2003 and is headquartered in Alpharetta, GA.

Market Capitalization: $75.24M
Prev close: $1.16
Average Daily Volume: 304,397
Days Low: $1.15
Year Low: $1.01
Year High: $5.15

ALIMERA SCIENCES INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 04 2021ALIMALIMERA SCIENCES I ...Holland DavidChief Marketing Off ...GrantA3.565001,78125,63025.1 K to 25.6 K (+1.99 %)
May 04 2021ALIMALIMERA SCIENCES I ...EISWIRTH RICHARD S JRPresident and CEOGrantA3.565001,78160,04359.5 K to 60 K (+0.84 %)
May 04 2021ALIMALIMERA SCIENCES I ...Jones John PhilipChief Financial Off ...GrantA3.564211,49919,56619.1 K to 19.6 K (+2.20 %)
Apr 12 2021ALIMALIMERA SCIENCES I ...Ashman PhilipChief Operating Off ...SellS9.624543319,37919.4 K to 19.4 K (-0.23 %)
Mar 10 2021ALIMALIMERA SCIENCES I ...Jones John PhilipChief Financial Off ...Payment of ExerciseF7.641,1648,89319,14520.3 K to 19.1 K (-5.73 %)
Mar 10 2021ALIMALIMERA SCIENCES I ...Holland DavidChief Operating Off ...Payment of ExerciseF7.421,93514,34825,13027.1 K to 25.1 K (-7.15 %)
Mar 08 2021ALIMALIMERA SCIENCES I ...Ashman PhilipChief Operating Off ...Payment of ExerciseF7.772,53319,68119,42422 K to 19.4 K (-11.54 %)
Jan 11 2021ALIMALIMERA SCIENCES I ...EISWIRTH RICHARD S JRPresident and CEOOption ExerciseA5.0152,500263,02552,500
Jan 11 2021ALIMALIMERA SCIENCES I ...EISWIRTH RICHARD S JRPresident and CEOGrantA0.0017,500059,54342 K to 59.5 K (+41.62 %)
Jan 11 2021ALIMALIMERA SCIENCES I ...Jones John PhilipChief Financial Off ...Option ExerciseA5.0116,87584,54416,875
Jan 11 2021ALIMALIMERA SCIENCES I ...Jones John PhilipChief Financial Off ...GrantA0.005,625017,98112.4 K to 18 K (+45.52 %)
Jan 11 2021ALIMALIMERA SCIENCES I ...Ashman PhilipChief Operating Off ...Option ExerciseA5.0130,000150,30030,000
Jan 11 2021ALIMALIMERA SCIENCES I ...Ashman PhilipChief Operating Off ...Option ExerciseA5.0130,000150,30030,000
Jan 11 2021ALIMALIMERA SCIENCES I ...Ashman PhilipChief Operating Off ...GrantA0.0010,000021,95712 K to 22 K (+83.63 %)
Jan 11 2021ALIMALIMERA SCIENCES I ...Ashman PhilipChief Operating Off ...GrantA0.0010,000021,95712 K to 22 K (+83.63 %)

View all ALIMERA SCIENCES INC insider transactions.